A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field ...

The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). A research team from Columbia Engineering and ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

Researchers identified a unique population of immune cells that significantly enhance treatment outcomes for relapsed acute myeloid leukemia (AML). Conducted in collaboration with the Dana Farber ...

In a paper published today in Science Immunology, the team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML).

Moreover, a part of AML-DC might exert tolerogenic effects on the immune system. Further investigation on this immunotherapeutical approach is necessary to define the best antigen format for this ...

For patients with AML, a stem cell transplant holds the potential for a cure. The goal of the transplant is to replace the patient’s hematopoietic stem cells – cells that rejuvenate supplies of blood ...

PROOF-OF-CONCEPT: ANT308 has shown strong single-agent anti-leukemia activity in two AML mouse models and synergistic ... on human T cells, overcoming immune suppression in the tumor microenvironment.

Subscribe for FREE For patients with AML, a stem cell transplant holds the potential for a cure. The goal of the transplant is to replace the patient’s hematopoietic stem cells – cells that rejuvenate ...